Pathologic Findings at Risk Reducing Surgery in <i>BRCA</i> and Non-<i>BRCA</i> Mutation Carriers: A Single-Center Experience

Risk-reducing surgery (RRS) is recommended in BRCA-mutated carriers because of their increased risk of developing ovarian cancer, while its role is still discussed for women harboring mutations in non-<i>BRCA</i> homologous repair genes. The aim of this study was to retrospectively evalu...

Full description

Bibliographic Details
Main Authors: Chiara Cassani, Chiara Rossi, Cristina Angela Camnasio, Mario Urtis, Giacomo Fiandrino, Maurizia Grasso, Francesca Zanellini, Marco Lucioni, Gioacchino D’Ambrosio, Alessandro Di Toro, Margherita Rossi, Marianna Roccio, Alberta Ferrari, Simona Secondino, Rossella Elena Nappi, Eloisa Arbustini, Marco Paulli, Arsenio Spinillo, Stefania Cesari
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/12/12/3054